ADDvise receives order from AstraZeneca in China worth 2.2 MSEK.


ADDvise has received an order from AstraZeneca in Wuxi, China, to
deliver laboratory furnishings and safety ventilation to a chemistry
laboratory and a microbiology laboratory. The order amounts to 2.2 MSEK
and will be delivered during 2015. The order will be delivered to
AstraZeneca\'s research and development laboratory in Wuxi.


\- This is the second order in China in a short time. It is exciting to
see that the interest in ADDvise solutions is growing on the gigantic
Chinese market. We see great potential for future growth in China, where
infrastructure investments is constantly increasing in line with
increased economic prosperity and increased life expectancy, says Rikard
Akhtarzand CEO of ADDvise, in a comment on today\'s order.

 

For further information, please contact:

Rikard Akhtarzand, CEO, +46 765-25 90 71

rikard.akhtarzand@addvisegroup.se

www.addvisegroup.com

 

About ADDvise Lab Solutions AB

ADDvise Lab Solutions AB (publ) is an expansive group which through its
subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise
Tillquist AB, Sonesta Medical AB, Sonesta Medical Inc and Surgical
Tables Inc. offers comprehensive solutions in the form of products and
services to healthcare and research facilities. ADDvise Group\'s
customers are located in both the private and public sectors. The
Company\'s share is listed on First North Premier and Mangold
Fondkommission AB, +46 8-503015 50, is the company\'s Certified Adviser
and liquidity provider.

Anhänge

ADDvise_receives_order_from_AstraZeneca_in_China_worth_2.2_MSEK_2015_03_05_74b0e.pdf
GlobeNewswire